Top 10 Pharma Companies in India (2026), Ranked by Revenue

• Updated 5 October 2026
• Reviewed by Sudhanshu Singhal
• 13 min read
• 33 sources

Top 10 pharma companies in India by revenue (FY2025-26)

How this list is ranked

This list is ranked by consolidated revenue for the financial year ended 31 March 2026, taken from each company's published results. Every figure in the table above comes from a company press release, an SEC filing or a reporting site linked under Sources, so you can check any number yourself.

Lists of "top pharma companies in India" you find online often differ from one another because they use different bases. Some rank by market capitalisation (market value), some by India sales alone, and many do not state any basis at all. This page shows the revenue ranking first and then gives two alternative views — India market share and market value — so you can see why rankings change depending on the yardstick.

The top 10 pharma companies in India, in detail

Below is a short profile of each company in the table, in rank order, covering its founding, headquarters, main therapy areas, well-known brands and stock listing.

Other ways to rank: India market share

Ranking by Indian retail sales gives a different order, because it counts only medicines sold in India. Companies that earn much of their revenue abroad rank lower here: Aurobindo, Biocon and Divi's are not in Pharmarack's top 40 by Indian sales. The table below shows the top 10 corporate groups by Indian sales according to Pharmarack PharmaTrac data for MAT March 2026.

The total Indian pharma retail market stood at ₹2,45,943 crore for MAT March 2026, growing 8.6% year on year. Sun Pharma held the first position in India by market share at 8.4% in MAT March 2026 and 8.5% in MAT June 2026. Abbott ranks second by India retail sales but is not in the FY26 revenue table above.

Other ways to rank: market value

Market capitalisation — the total value of a company's shares — is another way people rank pharma companies. It changes every trading day, so this view is a snapshot. The figures below are market capitalisation in ₹ crore on 5 October 2026.

You can see that Divi's Laboratories, which is 12th on the revenue list, is 2nd by market value. Market value reflects what investors expect a company to earn in the future, not what it earned last year. These values change daily.

Large unlisted pharma companies

Some large Indian pharma companies are not listed on the stock exchange. The latest figures we found for them are for FY25, from credit rating reports.

Intas Pharmaceuticals (Ahmedabad; founder Hasmukh Chudgar) reported consolidated operating income of ₹20,855.5 crore in FY25, according to an ICRA rating report of November 2025. Intas ranked 7th in India by sales (Pharmarack MAT March 2026). Its brands include Pregabid, Zoryl and Pantium.

Hetero Labs (Hyderabad; founder Dr B. Partha Saradhi Reddy, 1993) reported total operating income of ₹16,404 crore in FY25, according to a CARE Ratings report of September 2025. Hetero works in APIs, generics and antiretrovirals.

Macleods Pharmaceuticals (Mumbai) reported provisional revenue of ₹9,383 crore in FY25, according to a CARE Ratings report of August 2025. Macleods ranked 11th in India by sales (Pharmarack MAT March 2026). Its brands include Thyrox and Olmesar.

The Indian pharma industry in numbers

India's pharmaceutical sector is one of the largest in the world by both volume and value. Here are the key figures from Government of India and industry data.

• The domestic pharmaceutical market is worth about USD 60 billion and is projected to reach USD 130 billion by 2030.
• Total sector turnover stood at ₹4.72 lakh crore in FY25.
• India's pharma industry is the 3rd largest in the world by volume and 11th by value.
• India is the largest global supplier of generic medicines, accounting for about 20% of the world's generic supply.
• India supplies about 60% of UNICEF's vaccine requirements.
• Pharmaceutical exports were about USD 31 billion in FY26, with a government target of USD 50 billion by 2030.
• The Indian retail pharma market stood at ₹2,45,943 crore for MAT March 2026, growing 8.6% year on year.

Top-selling medicine brands in India

The following brands sold the most in India by value, according to Pharmarack data for MAT March 2026. This list is for information only. Prescription medicines must be taken only as prescribed by a doctor.

Alkem Laboratories has three brands — Pan, Clavam and Pan D — in this top 10 list. Cipla's Foracort is at number four.

Starting your own pharma business in India

Many people who want to enter the pharmaceutical business in India do so through the PCD franchise model, where you distribute a company's products in your own territory without setting up a manufacturing plant.

To start, you need a wholesale drug licence issued by the State Drug Control Department and GST registration. These are the basic legal requirements before you can purchase and distribute medicines.

Vibcare Pharma Pvt Ltd, based in Panchkula, Haryana and incorporated in 2014, works on this model. Vibcare appoints one PCD franchise partner per district and confirms monopoly rights in writing. You can read more about how the franchise works on the Vibcare PCD franchise page.

Frequently asked questions

Sources

Related reading

• Top 10 PCD pharma companies in India
• PCD pharma franchise with Vibcare
• Top 10 ayurvedic companies in India
• Retail and wholesale drug licence: documents required
• Role of a medical representative